Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Sartono, Erliyani ^a   Lisse, Ida M ^b   Terveer, Elisabeth M ^a   van de Sande, Paula J M ^a   Whittle, Hilton ^c   Fisker, Ane B ^d   Roth, Adam ^e   Aaby, Peter ^f   Yazdanbakhsh, Maria ^a   Benn, Christine S ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d STATENS SERUM INSTITUT   (Denmark)

^e LUND UNIVERSITY   (Sweden)

^f Iganga Mayuge Health and Demographic Surveillance Site   (Guinea-Bissau)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; ORAL POLIOMYELITIS VACCINE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; TUBERCULIN;

APPLICATION SITE SCAR; ARTICLE; BCG VACCINATION; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; LOW BIRTH WEIGHT; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; BIOSYNTHESIS; GUINEA-BISSAU; IMMUNITY; IMMUNOLOGY; MYCOBACTERIUM BOVIS; NEWBORN; SCAR; VACCINATION;

MYCOBACTERIUM TUBERCULOSIS;

BCG VACCINE; CICATRIX; CYTOKINES; GUINEA-BISSAU; HUMANS; IMMUNITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MYCOBACTERIUM BOVIS; POLIOVIRUS VACCINE, ORAL; TUBERCULIN; VACCINATION;

EID: 77956292692     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010328     Document Type: Article

References (28)

1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, et al. (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271: 698-702.
2. Fine PE (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339-45.
3. Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, et al. (1999) Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol 163: 2249-55.
4. Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Sanneh M, et al. (2002) Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol 168: 919-25.
5. Benn CS, Diness BR, Roth A, Nante E, Fisker AB, et al. (2008) Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ 336: 1416-20.
6. Diness BR, Fisker AB, Roth A, Yazdanbakhsh M, Sartono E, et al. (2007) Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine. Am J Clin Nutr 86: 1152-9.
7. Benn CS, Fisker AB, Rodrigues A, Ravn H, Sartono E, et al. (2008) Sexdifferential effect on infant mortality of oral polio vaccine administered with BCG at birth in Guinea-Bissau. A natural experiment. PLoS ONE 3(12): e4056.
8. Eriksson M, Sartono E, Martins CL, Balé C, Garly ML, et al. (2007) A comparison of ex vivo cytokine production in venous and capillary blood. Clin Exp Immunol 150: 469-76.
9. Bouros D, Zeros G, Panaretos C, Vassilatos C, Siafakas N (1999) Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test). Chest 99: 416-9.
10. Garly ML, Bale C, Martins CL, Baldé MA, Hedegaard KL, et al. (2001) BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. Vaccine 20: 468-74.
11. Barros AJ, Hirakata VN (2003) Alternatives for logistic regression in crosssectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3: 21.
12. Lalor MK, Ben-Smith A, Gorak-Stolinska P, Weir RE, Floyd S, et al. (2009) Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. J Infect Dis 199: 795-800.
13. Gunther J, Haas W, Von Boehmer H (1982) Suppression of T cell responses through competition for T cell growth factor (interleukin 2). Eur J Immunol 12: 247-9.
14. Stockinger B, Kassiotis G, Bourgeois C (2004) CD4 T-cell memory. Semin Immunol 16: 295-303.
15. Vekemans J, Ota MO, Wang EC, Kidd M, Borysiewicz LK, et al. (2002) T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol 127: 495-8.
16. Klein NP, Gans HA, Sung P, Yasukawa LL, Jhonson J, et al. (2010) Preterm infants' T cell responses to inactivated poliovirus vaccine. J Infect Dis 201: 214-22.
17. Anuradha B, Rakh SS, Ishaq M, Murthy KJR, Valluri VL (2008) Interferon-c low producer genotype +874 overrepresented in Bacillus Calmette-Guirin nonresponding children. Pediatr Infect Dis J 27: 325-9.
18. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178: 2243-7.
19. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-54.
20. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, et al. (1996) Interferongamma- receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 335: 1956-61.
21. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, et al. (1996) A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335: 1941-9.
22. Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P (2003) Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 38: 249-56.
23. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, et al. (1999) Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 180: 2069-73.
24. Marchant A, Amedei A, Azzurri A, Vekemans J, Benagiano M, et al. (2001) Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. Am J Respir Cell Mol Biol 24: 187-94.
25. Allende LM, López-Goyanes A, Paz-Artal E, Corell A, Garci{dotless}́a-Pérez MA, et al. (2001) A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency. Clin Diagn Lab Immunol 8: 133-7.
26. Cunningham JA, Kellner JD, Bridge PJ, Trevenen CL, Mcleod DR, et al. (2000) Disseminated bacille Calmette-Guérin infection in an infant with a novel deletion in the interferon-gamma receptor gene. Int J Tuberc Lung Dis 4: 791-4.
27. Dorman SE, Holland SM (1998) Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 101: 2364-9.
28. Dogan E, Erkoc R, Sayarlioglu H, Uzun K (2005) Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients. Ren Fail 27: 425-8.